Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

STTK

Shattuck Labs Inc

Oct 11 • 04:00PM ET

1.54

Dollar change +0.07
Percentage change 4.76	%

Healthcare • Biotechnology • USA • NASD

Peers: ADAP AFMD ALDX ALXO DTIL FATE GRTS HOOK IMTX KURA

| Held by: VTI VXF IWM VTWO IWO IWN IWC VTWG AVSC DFAT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.85	Insider Own	13.51%	Shs Outstand	47.26M	Perf Week	26.23%
Market Cap	73.50M	Forward P/E	-	EPS next Y	-1.07	Insider Trans	0.93%	Shs Float	41.28M	Perf Month	-58.27%
Income	-85.28M	PEG	-	EPS next Q	-0.42	Inst Own	71.93%	Short Float	13.21%	Perf Quarter	-66.45%
Sales	4.12M	P/S	17.84	EPS this Y	23.31%	Inst Trans	20.51%	Short Ratio	9.76	Perf Half Y	-83.51%
Book/sh	2.32	P/B	0.66	EPS next Y	31.91%	ROA	-60.08%	Short Interest	5.45M	Perf Year	-2.53%
Cash/sh	2.21	P/C	0.70	EPS next 5Y	-	ROE	-68.48%	52W Range	1.07 - 11.76	Perf YTD	-78.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-63.20%	ROI	-75.08%	52W High	-86.90%	Beta	1.79
Dividend TTM	-	Quick Ratio	7.62	Sales past 5Y	40.60%	Gross Margin	4.53%	52W Low	43.93%	ATR (14)	0.32
Dividend Ex-Date	-	Current Ratio	7.62	EPS Y/Y TTM	14.82%	Oper. Margin	-2195.80%	RSI (14)	29.39	Volatility	17.31% 14.33%
Employees	75	Debt/Eq	0.03	Sales Y/Y TTM	380.09%	Profit Margin	-2067.99%	Recom	2.20	Target Price	2.00
Option/Short	Yes / Yes	LT Debt/Eq	0.03	EPS Q/Q	15.58%	Payout	-	Rel Volume	0.85	Prev Close	1.47
Sales Surprise	222.57%	EPS Surprise	-1.38%	Sales Q/Q	704.50%	Earnings	Aug 01 AMC	Avg Volume	558.41K	Price	1.54
SMA20	-41.94%	SMA50	-50.44%	SMA200	-77.07%	Trades		Volume	472,072	Change	4.76%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-02-24	Downgrade	Needham	Buy → Hold
Oct-02-24	Downgrade	Citigroup	Buy → Neutral	$8 → $2
Oct-01-24	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-17-24	Downgrade	BTIG Research	Buy → Neutral
Aug-31-22	Initiated	BTIG Research	Buy	$12
Jun-01-22	Initiated	Citigroup	Buy	$13
May-02-22	Initiated	H.C. Wainwright	Buy	$28
Apr-14-21	Initiated	Berenberg	Buy	$47
Jan-11-21	Initiated	Evercore ISI	Outperform
Nov-03-20	Initiated	Needham	Buy	$34
Nov-03-20	Initiated	Cowen	Outperform
Nov-03-20	Initiated	Citigroup	Buy	$36

Show Previous Ratings

Oct-08-24 09:35AM	After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK) (Zacks) +11.50%
Oct-02-24 11:32AM	Shattuck Labs stock craters following pipeline and job cuts (Pharmaceutical Technology) -34.90%
06:57AM	Shattuck Labs Refocuses Strategy Amidst Restructuring and Cuts (TipRanks)
Oct-01-24 12:26PM	Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline (Benzinga) -44.99%
06:30AM	Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway (GlobeNewswire)
06:20PM	Loading…
Aug-01-24 06:20PM	Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.28%
04:05PM	Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights (GlobeNewswire)
Jul-30-24 05:00PM	Shattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology Conference (GlobeNewswire)
Jul-01-24 06:00AM	Shattuck Labs Announces Addition to Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
Jun-18-24 06:25PM	Yigal Nochomovitz Just Trimmed Price Target for Shattuck Labs, Inc. (NASDAQ:STTK) (Insider Monkey) -7.83% -9.26%
10:48AM	Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks (Insider Monkey)
Jun-14-24 01:28PM	Shattuck (STTK) Announces Positive Interim Data on Cancer Drug (Zacks) -9.50%
06:00AM	Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients (GlobeNewswire)
Jun-10-24 07:30AM	Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML) (GlobeNewswire)
Jun-06-24 07:30AM	Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients (GlobeNewswire)
09:35AM	Loading…
May-21-24 09:35AM	After Plunging -19.89% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK) (Zacks)
May-14-24 04:15PM	Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress (GlobeNewswire) -18.07%
May-07-24 12:00PM	What Makes Shattuck Labs (STTK) a New Buy Stock (Zacks)
09:55AM	Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect? (Zacks)
May-04-24 05:31AM	Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Results (GuruFocus.com)
May-02-24 09:58PM	STTK Stock Earnings: Shattuck Labs Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:25AM	Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:05AM	Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights (GlobeNewswire)
Apr-09-24 04:05PM	Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024 (GlobeNewswire) +8.44%
Apr-01-24 07:00AM	Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-04-24 07:00AM	Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors (GlobeNewswire)
Feb-29-24 04:05PM	Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights (GlobeNewswire) +10.54%
Feb-26-24 07:00AM	Shattuck Labs Announces Participation in Upcoming March Conferences (GlobeNewswire)
Feb-14-24 05:06AM	Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins (PR Newswire) +6.03%
Feb-13-24 06:00AM	Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases (GlobeNewswire) -5.37%
07:00AM	Loading…
Jan-08-24 07:00AM	Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024 (GlobeNewswire) +14.94%
Jan-04-24 04:05PM	Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +12.14%
Dec-21-23 08:00AM	Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants (GlobeNewswire)
Dec-13-23 10:45AM	Why Is Shattuck Labs (STTK) Stock Up 93% Today? (InvestorPlace) +130.33%
06:00AM	Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients (GlobeNewswire)
Dec-05-23 04:15PM	Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Data from the American Society of Hematology (ASH) 2023 Annual Meeting on December 13, 2023 (GlobeNewswire) +22.56%
Nov-14-23 09:00AM	Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference (GlobeNewswire) +10.05%
Nov-13-23 08:52AM	Shattuck Labs, Inc. (NASDAQ:STTK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 11:54PM	Q3 2023 Shattuck Labs Inc Earnings Call (Thomson Reuters StreetEvents) -23.21%
08:29AM	Shattuck Labs Inc (STTK) Reports Q3 2023 Financial Results and Business Updates (GuruFocus.com)
06:00AM	Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights (GlobeNewswire)
Nov-06-23 09:28AM	Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023 (GlobeNewswire) +14.05%
Nov-02-23 09:01AM	Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients at the American Society of Hematology (ASH) 2023 Annual Meeting (GlobeNewswire)
Oct-24-23 12:30PM	10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis (ACCESSWIRE) +7.69%
Aug-10-23 05:15PM	Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -8.64%
04:00PM	Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights (GlobeNewswire)
Jul-06-23 10:14AM	Companies Like Shattuck Labs (NASDAQ:STTK) Could Be Quite Risky (Simply Wall St.) -7.07%
May-25-23 05:15PM	Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting (GlobeNewswire) -5.46%
May-09-23 05:15PM	Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +5.56%
04:00PM	Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights (GlobeNewswire)
Apr-03-23 07:00AM	Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-21-23 11:50AM	Great week for Shattuck Labs, Inc. (NASDAQ:STTK) institutional investors after losing 37% over the previous year (Simply Wall St.)
Mar-16-23 08:31AM	Shattuck Labs Presents Preclinical Data at the 2023 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire) +8.93%
Mar-01-23 07:00AM	Shattuck Labs Announces Participation in Upcoming March Conferences (GlobeNewswire)
Feb-27-23 10:46PM	Shattuck Labs, Inc. (NASDAQ:STTK) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-23-23 04:30PM	Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-16-23 07:00AM	Shattuck Labs to Report Fourth-Quarter and Full-Year 2022 Financial Results on February 23, 2023 (GlobeNewswire)
Feb-09-23 06:01AM	Shattuck Labs Announces Participation in Upcoming SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-27-23 08:34AM	We Think Shattuck Labs (NASDAQ:STTK) Needs To Drive Business Growth Carefully (Simply Wall St.)
Jan-09-23 07:00AM	Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023 (GlobeNewswire)
Dec-13-22 06:51AM	Multiple insiders bought Shattuck Labs, Inc. (NASDAQ:STTK) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Dec-01-22 09:55AM	Shattuck Labs, Inc. (STTK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
Nov-11-22 05:51AM	Shattuck Labs Third Quarter 2022 Earnings: US$0.58 loss per share (vs US$0.41 loss in 3Q 2021) (Simply Wall St.)
Nov-08-22 04:30PM	Shattuck Labs Reports Third Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire) -6.75% -5.88%
Nov-07-22 08:00AM	Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Nov-04-22 11:55AM	Investors in Shattuck Labs (NASDAQ:STTK) have unfortunately lost 86% over the last year (Simply Wall St.)
Nov-03-22 08:30AM	Shattuck Labs Announces Participation in Upcoming November Conferences (GlobeNewswire)
Nov-01-22 04:30PM	Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022 (GlobeNewswire) -8.66%
Oct-12-22 10:04AM	Owning 38% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK), (Simply Wall St.) +10.51%
Oct-05-22 04:30PM	Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 8-12 (GlobeNewswire) +10.00%
Sep-01-22 04:15PM	Shattuck Labs Announces Participation in Upcoming September Conferences (GlobeNewswire)
Aug-20-22 08:41AM	We Think Shattuck Labs (NASDAQ:STTK) Needs To Drive Business Growth Carefully (Simply Wall St.)
Aug-11-22 07:00AM	Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire)
Jul-06-22 07:20AM	Quite a few insiders invested in Shattuck Labs, Inc. (NASDAQ:STTK) last year which is positive news for shareholders (Simply Wall St.) +20.93%
May-28-22 08:05AM	Shareholders in Shattuck Labs (NASDAQ:STTK) are in the red if they invested a year ago (Simply Wall St.)
May-13-22 08:50AM	Should You Buy Shattuck Labs (STTK) Ahead of Earnings? (Zacks)
May-12-22 07:00AM	Shattuck Labs Reports First Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire) +8.28%
May-06-22 09:00AM	Why Earnings Season Could Be Great for Shattuck Labs (STTK) (Zacks) -7.28%
May-05-22 09:14AM	What Type Of Shareholders Own The Most Number of Shattuck Labs, Inc. (NASDAQ:STTK) Shares? (Simply Wall St.) -7.03%
Apr-08-22 04:55PM	Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Apr-05-22 05:00PM	Shattuck Labs Announces Participation in Upcoming 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-21-22 12:00PM	Shattuck Labs, Inc. (NASDAQ:STTK) Analysts Just Trimmed Their Revenue Forecasts By 45% (Simply Wall St.) -7.81%
Mar-15-22 07:00AM	Shattuck Labs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights (GlobeNewswire)
Mar-09-22 08:21AM	Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Mar-02-22 08:39AM	Shattuck Labs Announces Participation in Upcoming March Conferences (GlobeNewswire) -6.99%
Feb-09-22 05:00PM	Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference (GlobeNewswire) -5.70%
Feb-02-22 01:38PM	Investment Management Of Virginia Llc Buys PowerShares QQQ Trust Ser 1, Dow Inc, Apple Inc, ... (GuruFocus.com) -9.30%
Jan-27-22 09:21AM	A Shattuck Labs, Inc. (NASDAQ:STTK) insider increased their holdings by 3.6% last year (Simply Wall St.) -5.75%
Jan-05-22 08:30AM	Shattuck Labs Announces Participation in Upcoming January Investor Conferences (GlobeNewswire) -6.49%
Dec-13-21 01:57PM	Shareholders in Shattuck Labs (NASDAQ:STTK) are in the red if they invested a year ago (Simply Wall St.) -5.02%
Dec-03-21 07:59PM	ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Shattuck Labs, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm (Newsfile)
Dec-02-21 03:40PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Shattuck Labs, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE) +7.02%
07:17AM	Shattuck Labs to Present at TIGIT Therapies Digital Summit 2021 (GlobeNewswire)
Dec-01-21 10:45PM	STTK BREAKING NEWS: ROSEN, A LEADING NATIONAL FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation - STTK (PR Newswire)
Nov-29-21 10:30AM	INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Shattuck Labs, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE) -8.50%
Nov-28-21 07:58PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Shattuck Labs, Inc. - STTK (Newsfile)
Nov-26-21 12:39PM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Shattuck Labs, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm (Business Wire) -7.19%
Nov-25-21 11:23PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Shattuck Labs, Inc. - STTK (PR Newswire)
05:00PM	ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Inquire About Class Action Investigation STTK (GlobeNewswire)
Nov-23-21 05:44PM	INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Shattuck Labs, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm (Business Wire) +5.48%

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schreiber Taylor	Chief Executive Officer	Oct 07 '24	Buy	1.21	36,500	44,220	71,002	Oct 08 06:05 AM
Brous Tyler	Director	Jun 27 '24	Buy	3.89	5,416	21,068	235,088	Jul 01 06:30 AM
Brous Tyler	Director	Jun 28 '24	Buy	3.90	3,000	11,700	238,088	Jul 01 06:30 AM
Schreiber Taylor	Chief Executive Officer	Jun 26 '24	Buy	3.47	14,400	50,011	34,502	Jun 26 04:15 PM
Schreiber Taylor	Chief Executive Officer	Jun 04 '24	Option Exercise	3.57	3,050	10,888	20,102	Jun 05 06:05 AM
Stout Stephen	See Remarks	Mar 06 '24	Option Exercise	3.54	11,109	39,380	85,791	Mar 08 05:40 PM
Stout Stephen	See Remarks	Mar 06 '24	Sale	10.53	16,004	168,522	74,437	Mar 08 05:40 PM
Neill Andrew R	Chief Financial Officer	Jan 10 '24	Sale	10.00	25,000	250,000	173,446	Jan 16 04:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STTK

Shattuck Labs Inc

Upgrade your FINVIZ experience